c-myc_NN
mRNA_NN
expression_NN
in_IN
minor_JJ
salivary_JJ
glands_NNS
of_IN
patients_NNS
with_IN
Sjogren_NN
's_POS
syndrome_NN
._.

c-myc_NN
protooncogene_NN
is_VBZ
implicated_VBN
in_IN
the_DT
pathogenesis_NN
of_IN
B_NN
cell_NN
lymphoid_JJ
malignancies_NNS
and_CC
high_JJ
levels_NNS
of_IN
c-myc_NN
mRNA_NN
expression_NN
are_VBP
observed_VBN
in_IN
activated_VBN
blood_NN
mononuclear_JJ
cells_NNS
._.

Sjogren_NN
's_POS
syndrome_NN
-LRB-_-LRB-
SS_NN
-RRB-_-RRB-
is_VBZ
characterized_VBN
by_IN
lymphocytic_JJ
infiltrates_NNS
of_IN
exocrine_JJ
glands_NNS
,_,
remarkable_JJ
B_NN
cell_NN
hyperreactivity_NN
and_CC
a_DT
strong_JJ
predisposition_NN
to_TO
B_NN
cell_NN
neoplasia_NN
._.

In_IN
this_DT
study_NN
,_,
c-myc_NN
protooncogene_NN
mRNA_NN
expression_NN
in_IN
29_CD
labial_JJ
minor_JJ
salivary_JJ
gland_NN
biopsies_NNS
from_IN
patients_NNS
with_IN
primary_JJ
SS_NN
and_CC
15_CD
controls_NNS
was_VBD
examined_VBN
using_VBG
in_FW
situ_FW
hybridization_NN
histochemistry_NN
._.

Two_CD
40mer_JJ
oligonucleotides_NNS
from_IN
the_DT
1st_NN
and_CC
the_DT
2nd_JJ
exon_NN
of_IN
the_DT
c-myc_NN
gene_NN
,_,
labeled_VBN
with_IN
35S_NN
,_,
were_VBD
used_VBN
as_IN
probes_NNS
._.

To_TO
detect_VB
the_DT
origin_NN
of_IN
the_DT
cell_NN
hybridized_VBN
with_IN
a_DT
c-myc_NN
probe_NN
,_,
a_DT
combined_JJ
immunochemistry_NN
in_FW
situ_FW
hybridization_NN
histochemistry_NN
technique_NN
was_VBD
used_VBN
._.

High_JJ
c-myc_NN
mRNA_NN
expression_NN
was_VBD
detected_VBN
on_IN
acinar_JJ
epithelial_JJ
cells_NNS
._.

c-myc_NN
did_VBD
not_RB
correlate_VB
with_IN
c-fos_NN
and_CC
c-jun_NN
protein_NN
expression_NN
._.

Stronger_JJR
c-myc_NN
mRNA_NN
expression_NN
was_VBD
detected_VBN
in_IN
labial_JJ
salivary_JJ
glands_NNS
of_IN
patients_NNS
with_IN
longer_JJR
disease_NN
duration_NN
-LRB-_-LRB-
p_NN
less_JJR
than_IN
or_CC
equal_JJ
to_TO
0.002_CD
-RRB-_-RRB-
and_CC
more_RBR
intense_JJ
T_NN
lymphocyte_NN
infiltrates_NNS
-LRB-_-LRB-
p_NN
less_JJR
than_IN
0.05_CD
-RRB-_-RRB-
although_IN
these_DT
patients_NNS
revealed_VBD
no_DT
hypergammaglobulinemia_NN
._.

No_DT
correlation_NN
was_VBD
observed_VBN
between_IN
c-myc_NN
mRNA_NN
and_CC
B_NN
lymphocyte_NN
monoclonicity_NN
or_CC
lymphoma_NN
._.

In_IN
conclusion_NN
,_,
strong_JJ
c-myc_NN
mRNA_NN
expression_NN
was_VBD
observed_VBN
on_IN
epithelial_JJ
cells_NNS
of_IN
labial_JJ
salivary_JJ
glands_NNS
from_IN
patients_NNS
with_IN
primary_JJ
SS_NN
._.

Our_PRP$
findings_NNS
may_MD
indicate_VB
the_DT
presence_NN
of_IN
a_DT
reactivated_VBN
virus_NN
hosted_VBN
in_IN
these_DT
cells_NNS
._.

